BioInvent International AB announced the appointment of Cecilia Hofvander as Senior Director Investor Relations, a new position at BioInvent covering external communications and investor relations. She will take office within three months and report directly to CEO Martin Welschof. Cecilia has broad experience within investor relations from positions within publicly listed companies in the biotech industry, including Active Biotech, Abliva and most recently at Alligator Bioscience. She holds a B.Sc in Chemistry and Molecular Biology from Lund University and has completed the Communication Executive Program at the Stockholm School of Economics. Apart from IR and Communication, Cecilia Hofvander's experience includes business development and international clinical drug trials.